[HTML][HTML] Comparison of a novel flexible progestin primed ovarian stimulation protocol and the flexible gonadotropin-releasing hormone antagonist protocol for assisted …

S Yildiz, E Turkgeldi, B Angun, A Eraslan, B Urman… - Fertility and sterility, 2019 - Elsevier
Objective To determine whether a flexible progestin primed ovarian stimulation (fPPOS)
protocol is effective for preventing premature ovulation. Design Retrospective cohort study …

GnRH antagonist protocol versus progestin-primed ovarian stimulation in patients with polycystic ovary syndrome: a systematic review and meta-analysis

R Deng, J Wang, J He, X Lei, D Zi, W Nong… - Archives of Gynecology …, 2024 - Springer
Purpose The aim of this meta-analysis was comparing the efficacy of GnRH antagonist
(GnRH-ant) protocol and progestin-primed ovarian stimulation (PPOS) in polycystic ovarian …

Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols

E Mathieu d'Argent, C Ferrier, C Zacharopoulou… - Journal of ovarian …, 2020 - Springer
Background PPOS protocols, initially described for FP in women with cancer, have many
advantages compared to antagonist protocols. PPOS protocols were not evaluated for …

Progesterone-primed ovarian stimulation in polycystic ovarian syndrome: an RCT

M Eftekhar, M Hoseini, L Saeed - International journal of …, 2019 - pmc.ncbi.nlm.nih.gov
Background In vitro fertilization is an important therapy for women with polycystic ovarian
syndrome (PCOS). The use of new ways of improving clinical results is yet required …

[HTML][HTML] Progestin-primed ovarian stimulation versus GnRH antagonist protocol in poor responders: Risk of premature LH surge and outcome of oocyte retrieval

TC Kao, YC Hsieh, IJ Yang, MY Wu, MJ Chen… - Journal of the Formosan …, 2023 - Elsevier
Purpose For poor ovarian responders (PORs), gonadotropin-releasing hormone (GnRH)
antagonist was commonly used for prevention of premature LH surge during controlled …

Superovulating cattle with corifollitropin-alpha, a long-acting recombinant human FSH (rhFSH): Dose-response, half-life, effects on the ovaries, and embryo outcomes

JHM Viana, RM de Moura, LP Martins, RA Figueiredo… - Theriogenology, 2024 - Elsevier
The aim of this study was to evaluate the superestimulatory and superovulatory responses of
cattle treated with corifollitropin-alpha, a long-acting human recombinant FSH (rhFSH). In …

Impact of progestin ovarian stimulation on newborn outcomes: a meta-analysis

I Zolfaroli, GA Ferriol, JJH Mora, A Cano - Journal of assisted reproduction …, 2020 - Springer
Objectives To compare progestin ovarian stimulation protocols with gonadotropin-releasing
hormone analogue (agonists and antagonists) protocols on newborn outcomes. Methods …

Medroxyprogesterone acetate affects sex differentiation and spermatogenesis in zebrafish

WJ Shi, DD Ma, YX Jiang, L **e, JN Zhang, GY Huang… - Aquatic Toxicology, 2019 - Elsevier
Medroxyprogesterone acetate (MPA) is a widely used synthetic progestin and it has been
frequently detected in aquatic environments. However, its effects on aquatic organisms …

Progesterone-primed ovarian stimulation in oocyte donation: a model for elective fertility preservation?

M Devesa, A Racca, E Clúa, C Casato, S García… - Reproductive …, 2022 - Elsevier
Research question Does type of LH peak suppression (progesterone-primed ovarian
stimulation [PPOS] versus gonadotrophin releasing hormone [GnRH] antagonist) affect …

[HTML][HTML] Validating the use of corifollitropin alfa in progestin-primed ovarian stimulation protocol on normal and high responders by comparing with conventional …

CY Huang, GY Chen, ML Shieh, HY Li - Life, 2020 - mdpi.com
Our previous study showed a satisfactory reproductive outcome resulting from the patient-
friendly ovarian stimulation protocol using long-acting follicle stimulation hormone (FSH) …